Novel treatment for orphan cardiomyopathies
Project Cor is committed to transforming the way we combat specific segments of Cardiomyopathy with its focus on repurposed drugs of orphan indications (rare diseases without specific drug treatments). Such detrimental diseases are some of the most significant causes of Heart Failure — an ailment that heavily impact on a large spectrum of the CVD population.
At this event, attendees will have a chance to
Get to know the Company;
Meet the Team behind Project Cor;
Receive the latest update from the Company;
Gain insights on the current opportunity;
Ask the questions you want answered.
May 22nd, 2024
12pm - 1pm AEST
Wednesday 22 May 2024
Timing does not suit? Please book in anyway and we will send you a link to the recording.